This provider's $10.4M in total Medicare payments ranks in the 91th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 1956% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 844% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $99.76 | $15.22 | 6.55x | $84.54 | $36.4K | 2.8K | 2.7K |
| 2017 | $172.01 | $23.69 | 7.26x | $148.32 | $343.8K | 20.3K | 15.9K |
| 2018 | $242.36 | $114.51 | 2.12x | $127.85 | $2.0M | 35.9K | 28.1K |
| 2019 | $244.34 | $82.79 | 2.95x | $161.55 | $2.6M | 38.9K | 30.3K |
| 2020 | $197.34 | $80.21 | 2.46x | $117.13 | $2.3M | 40.2K | 24.7K |
| 2021 | $43.93 | $28.87 | 1.52x | $15.06 | $1.2M | 35.7K | 21.3K |
| 2022 | $29.91 | $25.24 | 1.19x | $4.67 | $1.1M | 34.3K | 19.7K |
| 2023 | $31.28 | $25.38 | 1.23x | $5.90 | $748.6K | 23.8K | 15.5K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 22.5K | $2.0M | $90.57 | 3.85x |
| G0481 | Drug test def 8-14 classes | 10.8K | $1.7M | $154.49 | 2.79x |
| 81408 | Molecular pathology procedure level 9 | 734 | $1.4M | $2.0K | 1.17x |
| 80307 | Testing for presence of drug | 8.8K | $561.4K | $63.63 | 3.84x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 569 | $435.2K | $764.89 | 1.02x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) full sequence analysis | 571 | $384.4K | $673.22 | 1.05x |
| 81407 | Molecular pathology procedure level 8 | 300 | $249.1K | $830.24 | 1.02x |
| G0480 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 1.8K | $204.8K | $113.00 | 3.71x |
| 81406 | Molecular pathology procedure level 7 | 731 | $202.7K | $277.34 | 1.04x |
| 84443 | Blood test, thyroid stimulating hormone (TSH) | 9.1K | $168.3K | $18.45 | 5.70x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 10.5K | $148.4K | $14.13 | 6.17x |
| 82306 | Vitamin D-3 level | 4.4K | $143.2K | $32.72 | 5.60x |
| 80053 | Blood test, comprehensive group of blood chemicals | 12.7K | $139.7K | $11.02 | 5.43x |
| 81226 | Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) common variants | 316 | $139.6K | $441.69 | 1.26x |
| 81298 | Gene analysis (mutS homolog 6 [E coli]) full sequence analysis | 213 | $134.0K | $629.01 | 1.03x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 14.4K | $123.3K | $8.58 | 5.77x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 4.9K | $122.3K | $24.92 | 1.11x |
| 81225 | Gene analysis (cytochrome P450, family 2, subfamily C, polypeptide 19) common variants | 389 | $111.1K | $285.70 | 1.34x |
| 84481 | Thyroid hormone, T3 measurement | 5.1K | $96.5K | $18.78 | 5.76x |
| 81211 | Gene analysis (breast cancer 1 and 2) full sequence and common duplication or deletion variants | 36 | $84.5K | $2.3K | 1.02x |
This provider submits charges 3.03 times higher than what Medicare actually pays.
A markup ratio of 3.03x means for every $100 Medicare pays, this provider initially charges $303. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Raritan, NJ | $1.2B | ⚠️ Flagged |
| Quest Diagnostics Incorporated | Clifton, NJ | $927.2M | ⚠️ Flagged |
| Bioreference Health, Llc | Elmwood Park, NJ | $841.0M | ⚠️ Flagged |
| Accu Reference Medical Lab, Llc | Linden, NJ | $204.9M | ⚠️ Flagged |
| Aculabs Inc | East Brunswick, NJ | $91.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data